Monographie - Penicillin G sodium

Laatste update :
19/11/2024

Penicillin G sodium

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Benapen	Brazilië
Bencilpenicilina	Chili, Ecuador, Peru
Benpen	Australië, nieuw Zeeland
Bensylpenicillin	Zweden
Benzapen	Iran
Benzatec	Zuid-Afrika
Benzatron	Brazilië
Benzylpenicillin	Denemarken, Egypte, Finland, Noorwegen, Zweden
Benzylpenicilline	Tunisie
Biconcillina	Ecuador
Crystapen	Canada, Groot Britannië, Ierland
Declin	Mexico
Fortepen	Saudi-Arabië
Geepenil	Finland
Natrium penicillin G	Nederland
Novopen	Zuid-Afrika
Pebencil	Venezuela
Penbendox	Mexico
Penibiot	Spanje
Penicillin	Noorwegen
Penicillina G sodica	Argentinië, Chili, Colombia, Ecuador, Portugal
Penilevel	Spanje
Sodiopen	Spanje
Unicillina	Spanje

Literatuur : Penicillin G sodium

	type	publicatie
13	Artikel	Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440	Artikel	Stiles ML, Tu YH, Allen LV. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057	Artikel	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072	Artikel	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241	Artikel	Rayani S, Jamali F. The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Can J Hosp Pharm 1985 ; 38: 162-163.
1263	Artikel	Allwood MC, Brown PW. The effect of buffering on the stability of reconstituted benzylpenicillin injection. Int J Pharm Pract 1992 ; 1: 242-244.
1725	Artikel	Oliver C, Law S. Compatibility of oxytocin, zidovudine, and penicillin G. Can J Hosp Pharm 2001 ; 54: 112-113.
2056	Artikel	Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004 ; 53: 675-677.
2087	Artikel	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	Artikel	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
3012	Artikel	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3227	Artikel	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	fabrikant	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	fabrikant	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3540	fabrikant	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3549	fabrikant	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3580	fabrikant	Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016
3585	fabrikant	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	fabrikant	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3648	Artikel	Hossain M.A, Friciu M, Aubin S, Leclair G. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Am J Health-Syst Pharm 2014 ; 71:669-673.
3674	fabrikant	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3702	Artikel	McDougall D.A.J, McWhinney. Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931	fabrikant	Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 2016
3964	Artikel	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	fabrikant	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	Artikel	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Artikel	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4590	Artikel	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603	Artikel	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4831	Artikel	Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I. Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr 2022 ;111:2307–2314.
4837	Artikel	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales